The effects of surgical and transcatheter aortic valve replacement for aortic stenosis on regression and progression of mitral regurgitation -a propensity score matched analysis

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

About the speaker

Doctor Shirit Kazum

Rabin Medical Centre, Petah Tikva (Israel)

9 More presentations in this session

Presentation thumbnail

Discussant - Treatment of aortic stenosis and TAVI

Presentation thumbnail

Sex-related differences in reverse cardiac remodeling after transcatheter aortic valve replacement: focus on the right side of the heart

Doctor C. Olmos (Madrid, ES)

Abstract Slides

Presentation thumbnail

Quality-of-life improvement of the 100 patients treated over the Valvosoft prospective, multi-centre, single-arm first-in-human and pivotal studies: 12 month follow-up.

Professor E. Messas (Paris, FR)

Presentation thumbnail

Transcatheter aortic valve implantation without cardiac surgery backup: single-center experience assessing safety and efficacy outcomes

Mr A. Rocha De Almeida (Evora, PT)

Presentation thumbnail

Role of VA ECMO for patients with cardiogenic shock associated with severe aortic valve dysfunction as a bridge to trans-catheter or surgical valve replacement

Mr J. Castro Martin (San Cristobal De La Laguna, ES)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Treatment of aortic stenosis and TAVI

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Mitral regurgitation in TAVR patients: identifying risk factors for long-term persistence

Congress Presentation

Prognostic significance of functional mitral regurgitation in heart failure patients undergoing cardiac resynchronization therapy

Congress Session

Registries on valvular heart disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources